CD69 and metastatic melanoma: Interestingly, this hypothesis has recently been supported in the metastatic melanoma setting (40), where the persistence of neoantigen-specific TCRs after TIL-ACT correlated with CD39–CD69– stem-like T cells capable of self-renewal, differentiation, and further expansion upon stimulation.